Forward Industries, Inc. — FY2012 Form 10-K
Business context and reporting period. The filing covers the fiscal year ended September 30, 2012; it is an annual report, not a standalone fourth-quarter report. Forward designs and distributes custom carrying and protective products, principally for OEM customers, and sources most products from China. In June 2012, it decided to exit its global retail business and concentrate on OEM operations. Retail results are reported as discontinued operations.
Financial performance and liquidity
| Metric | FY2012 | FY2011 |
|---|---|---|
| Continuing-operations net sales | $29.4 million | $22.8 million |
| Gross profit / gross margin | $4.0 million / 13.5% | $5.1 million / 22.3% |
| Loss from continuing operations | $3.3 million | $2.0 million |
| Loss from discontinued operations | $6.3 million | $0.9 million |
| Consolidated net loss | $9.6 million | $2.9 million |
| Net cash used in operating activities | $10.8 million | $1.8 million |
- Continuing-operations sales rose 29%, but gross profit fell 22%; gross margin contracted by about 8.8 percentage points. Operating loss from continuing operations was $3.3 million, versus $2.1 million in FY2011.
- At September 30, 2012, cash and cash equivalents were $4.6 million, marketable securities $0.4 million, and working capital $9.1 million. The company reported a 2.15 current ratio and a 1.67 quick ratio, with no short- or long-term debt.
- Cash declined from $14.9 million at FY2011 year-end. Operating cash use reflected the net loss and working-capital investment, including increases in receivables and inventory. Investing activities provided $0.5 million; there were no financing activities.
- Total assets were $17.1 million and shareholders’ equity was $9.2 million at year-end, compared with $22.3 million and $18.7 million, respectively, in FY2011.
Material changes and unusual items
- Diabetic-product sales increased 30% to $21.7 million and represented 74% of continuing-operations sales. Other-product sales rose 26% to $7.7 million.
- Three customers accounted for 62% of continuing-operations sales and 76% of receivables at year-end. Four Chinese suppliers provided about 90% of products purchased; one supplier represented 54% of purchases.
- Margin decline reflected customer price concessions, higher supplier costs, lower-margin programs, and quality remediation. Quality-related inspection, warehousing, handling, and freight costs reduced FY2012 gross margin by approximately 3 percentage points. The company also reported transition and termination costs from its sourcing restructuring.
- Discontinued operations recorded $2.2 million of sales but a $1.9 million gross loss and $4.4 million of operating expenses. Charges included $2.8 million for returns, discounts, and price protection, inventory write-downs, and forfeited supplier advances.
- Sales and marketing expense decreased 35% to $1.7 million, while general and administrative expense increased 20% to $5.6 million, including higher legal, professional, personnel, and relocation-related costs. FY2012 also included $250,000 of severance expense for former co-CEO Brett Johnson.
Outlook, risks, and contingencies
- Management said available liquidity should be adequate for the next 12 months, while acknowledging substantial recent operating losses and cash use. It gave no quantified profitability or revenue guidance and said profitability in 2013 was not assured.
- Management expected lower overhead from headcount reductions, office closures, the Florida headquarters relocation, and a lower-cost Asia sourcing arrangement. It anticipated that new, lower-margin programs would remain a significant part of FY2013 sales and that customer pricing pressure would continue to weigh on margins.
- The company expected an additional $0.2–$0.4 million loss from exiting retail between October 2012 and January 2013. The filing gives different expected completion dates in different sections—January 31, 2013 in the MD&A and discontinued-operations note, and December 31, 2012 in the segment note.
- The exclusive buying-agent and supply agreement runs to March 2014, subject to renewal. The agent is a company whose principal is a Forward director; FY2012 service fees were $691,000. This arrangement, along with reliance on Chinese suppliers, presents execution and related-party oversight considerations.
- Other key risks include dependence on a few diabetic-product customers, possible changes to customers’ in-box practices, pricing and currency pressure, foreign-supplier quality and delivery risks, and variability in customer orders. The company does not maintain credit insurance for all receivables.
- A lawsuit involving Targus was settled effective October 17, 2012; substantially all of the settlement payment was covered by insurance. A separate Dutch VAT guarantee was approximately $96,000, secured by assets held at a Swiss bank; no liability had been incurred under it at year-end.
- Management concluded disclosure controls and internal control over financial reporting were effective at year-end. The independent auditor issued an unqualified opinion on the financial statements.
Investor facts to verify
- Whether the OEM-focused restructuring and cost reductions can restore profitability and reduce operating cash burn.
- How customer concentration, order variability, and continued margin pressure affect FY2013 sales and gross margins.
- Whether receivables and inventory growth convert to cash, and how the reduced cash balance supports the stated 12-month liquidity outlook.
- The retail-exit completion date, remaining liabilities, and final costs; the filing’s dates differ by section.
- The terms, fees, governance safeguards, and operating results of the buying-agent relationship involving a director’s principal.